In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 24, 2020
Clear
SKU: GMS-2133 Category:

The global market for in vivo toxicology is projected to hit USD 8.23 billion by 2025, rising over the forecast period at a CAGR of 5.87%. Increasing pharmaceutical R&D activities, compulsory government legislation for animal research, creativity in animal models and the production of exclusive in vivo toxicology tests are some main factors driving market growth.

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 1

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 2

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 3

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 4

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 5

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 6

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 7

In Vivo Toxicology Market by Testing type (Chronic, Sub-chronic), Product (Instruments, Consumables), Toxicity Endpoints (Systemic, DART, Immunotoxicity), Testing Facility (Outsourced, In-house) - 2020 to 2025 8

1 Global In Vivo Toxicology Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global In Vivo Toxicology Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global In Vivo Toxicology Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global In Vivo Toxicology Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global In Vivo Toxicology Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global In Vivo Toxicology Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global In Vivo Toxicology Market – By Product (Market Size – & million/billion)
8.1 Mice Models
8.2 Rat Models
8.3 Consumables
8.4 Other Animal Models
8.5 Instruments

9 Global In Vivo Toxicology Market – By Testing Type
9.1 Chronic Toxicity Testing
9.2 Sub-chronic Toxicity Testing
9.3 Sub-acute Toxicity Testing
9.4 Acute Toxicity Testing

10 Global In Vivo Toxicology Market – By Toxicity Endpoint
10.1 Immunotoxicity
10.2 Systemic Toxicity
10.3 Carcinogenicity
10.4 Genotoxicity
10.5 Developmental and Reproductive Toxicity (DART)
10.6 Other

11 Global In Vivo Toxicology Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global In Vivo Toxicology Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global In Vivo Toxicology Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific
13.3 Eurofins Scientific
13.4 Perkinelmer
13.5 SRI International
13.6 Danaher
13.7 The Jackson Laboratory
13.8 Charles River Laboratories
13.9 Labcorp
13.10 Data Sciences International
13.11 Envigo
13.12 Company 11 & more

14 Global In Vivo Toxicology Market – Appendix
14.1 Sources
14.2 Abbreviations